lysophosphatidylethanolamine (0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Term ID

CHEBI:72749

Synonyms

(2R)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
LPE 0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)
LPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Lyso-PE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE 0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)
PE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Definition

A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: 2-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 22:6

2-acyl-sn-glycero-3-phosphoethanolamine lysophosphatidylethanolamine 22:6 Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Show first 5 Terms
has_role: metabolite

metabolite Show first 5 Terms

Phenotype

Phenotype resulting from lysophosphatidylethanolamine (0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Phenotype where environments contain lysophosphatidylethanolamine (0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Phenotype modified by environments containing lysophosphatidylethanolamine (0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Human Disease Model